glp-1 options for type 2 diabetes and obesity 2025 How Supply Demand Weight Loss Drugs is Playing Out in 2026 GLP-1s for Weight Loss: What

One in five (19%) insured adults who have taken GLP-1s say they paid for the full cost themselves

There is no indication that GLP-1s have negatively impacted medtech volumes or pricing

he is also a developer of novel biological drugs, including GLP-1 agonists, and holds several US patents in the field

Optum Rx can provide precision analytics to demonstrate cost impacts spanning multiple scenarios as well as expert clinical consultation and insights to help you make timely decisions

After one year, patients switching from Wegovy maintained about 82% of their prior weight loss, while patients switching from Zepbound maintained about 78%

GLP-1 receptor agonists like semaglutide take the spotlight, enhancing insulin secretion in response to elevated blood sugar levels